Archive for December, 2008

Internal Medicine News - OTC antihistamine/decongestant

Wednesday, December 31st, 2008

Clarinex-D 12 Hour is now available over the counter for relief of nasal and non-nasal symptoms of seasonal allergic rhinitis in patients aged 12 years and older. The tablets combine desloratadine (2.5 mg) with pseudoephe…

Drug Store News - Schering-Plough files Clarinex NDA

Sunday, December 28th, 2008

Schering-Plough, maker of the blockbuster antihistamine Claritin (loratadine) has filed a new drug application with the Food and Drug Administration to broaden the indication of its new drug Clarinex 5mg (desloratadine). Schering says Clarinex, positioned as a successor to the manufacturer’s blockbuster Claritin, currently t…

Drug Store News - Schering-Plough’s Clarinex receives more allergy indications

Thursday, December 25th, 2008

Schering-Plough’s Clarinex (desloratadine), positioned as a successor to Claritin (loratadine), received the green light from the FDA to be marketed as a treatment for allergic rhinitis. The new indication broadens the drug’s initial use as a treatment for seasonal allergic rhinitis. Expanded labeling for Clarinex also notes it can be used safely…

Chain Drug Review - Clarinex-D is cleared for treatment of allergies

Saturday, December 20th, 2008

The Food and Drug Administration has approved Clarinex-D, a nondrowsy antihistamine formulated with a decongestant. According to manufacturer Schering-Plough Corp., a unique gel control delivery system in the product provides effective 24-hour relief from symptoms of seasonal allergic rhinitis. The drug, av…

Knight Ridder/Tribune Business News - Blue Cross Pushes Claritin Alternative.

Friday, December 19th, 2008

By Deborah Crowe, Ventura County Star, Calif. Knight Ridder/Tribune Business News
Dec. 25–Thousand Oaks-based WellPoint Health Networks is distributing temporary discounts for a new over-the-counter Claritin alternative to Blue Cross…

Business Wire - Research and Markets: Benchmark Schering-Ploughs Performance against Key Rivals In The Ethical Pharmaceutical Sector

Monday, December 15th, 2008

DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/reports/c43905) has announced the addition of Schering-Plough: PharmaVitae Profile to their offering.
This analysis examines the historical and forecast performance for Schering-Plough in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key …

Prevention Steps And Medications For Indoor Allergies

Tuesday, December 9th, 2008

Antihistamines include older antihistamines, also called first-generation antihistamines, and newer second-generation antihistamines.

First-generation antihistamines most of these antihistamines are available without a prescription, such as diphenhydramine (Benadryl), clemastine (Tavist), and chlorpheniramine (Chlor-Trimeton Allergy). These older antihistamines are more likely to cause drowsiness. Depe…

They Don't Make'em Like They Use To

Friday, December 5th, 2008

In a society that relentlessly bombards the you with advertising, you are constantly hearing about “New and Improved” or “Better than Ever”. Although many of the big drug companies claim to be producing the most innovative new drugs, they are just hiding behind there smoke screen of advertisement. In this article well look at just how effective are new drugs versus the old ones and what has led America to producing less innovativ…